81 related articles for article (PubMed ID: 23219015)
1. T-cell receptor repertoire usage in hematologic malignancies.
Fozza C; Longinotti M
Crit Rev Oncol Hematol; 2013 Jun; 86(3):201-11. PubMed ID: 23219015
[TBL] [Abstract][Full Text] [Related]
2. Study of the T-cell receptor repertoire by CDR3 spectratyping.
Fozza C; Barraqueddu F; Corda G; Contini S; Virdis P; Dore F; Bonfigli S; Longinotti M
J Immunol Methods; 2017 Jan; 440():1-11. PubMed ID: 27823906
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. The T Cell Receptor Repertoire Diversity Following Hematopoietic Stem Cell Transplantation.
Zamani F; Mirfakhraie R; Safaee Nodehi SR; Mollaei-Kandelous Y; Jafari H; Farahmand M; Rezaei F; Teymoori-Rad M; Movafagh A
Iran J Allergy Asthma Immunol; 2022 Oct; 21(5):584-593. PubMed ID: 36341566
[TBL] [Abstract][Full Text] [Related]
5. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
[TBL] [Abstract][Full Text] [Related]
6. Fractal organization of the human T cell repertoire in health and after stem cell transplantation.
Meier J; Roberts C; Avent K; Hazlett A; Berrie J; Payne K; Hamm D; Desmarais C; Sanders C; Hogan KT; Archer KJ; Manjili MH; Toor AA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):366-77. PubMed ID: 23313705
[TBL] [Abstract][Full Text] [Related]
7. Skewed T cell receptor repertoire of Vdelta1(+) gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction.
Fujishima N; Hirokawa M; Fujishima M; Yamashita J; Saitoh H; Ichikawa Y; Horiuchi T; Kawabata Y; Sawada KI
Clin Exp Immunol; 2007 Jul; 149(1):70-9. PubMed ID: 17425654
[TBL] [Abstract][Full Text] [Related]
8. Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases.
Pandolfi F; Cianci R; Casciano F; Pagliari D; De Pasquale T; Landolfi R; Di Sante G; Kurnick JT; Ria F
J Biol Regul Homeost Agents; 2011; 25(2):153-61. PubMed ID: 21880203
[TBL] [Abstract][Full Text] [Related]
9. Immune Modulation in Hematologic Malignancies.
Dhodapkar MV; Dhodapkar KM
Semin Oncol; 2015 Aug; 42(4):617-25. PubMed ID: 26320065
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of the stem cell as a target for hematologic malignancies.
Ballen KK; Becker PS; Stewart FM; Quesenberry PJ
Semin Oncol; 2000 Oct; 27(5):512-23. PubMed ID: 11049019
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse.
Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M
Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638
[TBL] [Abstract][Full Text] [Related]
12. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
13. A history of bone marrow transplantation.
de la Morena MT; Gatti RA
Immunol Allergy Clin North Am; 2010 Feb; 30(1):1-15. PubMed ID: 20113883
[TBL] [Abstract][Full Text] [Related]
14. Increased adenosine triphosphate production by peripheral blood CD4+ cells in patients with hematologic malignancies treated with stem cell mobilization agents.
Manga K; Serban G; Schwartz J; Slotky R; Patel N; Fan J; Bai X; Chari A; Savage D; Suciu-Foca N; Colovai AI
Hum Immunol; 2010 Jul; 71(7):652-8. PubMed ID: 20381567
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
[TBL] [Abstract][Full Text] [Related]
16. Update on non-myeloablative stem cell transplantation for hematologic malignancies.
Giralt S
Int J Hematol; 2002 Aug; 76 Suppl 1():368-75. PubMed ID: 12430884
[TBL] [Abstract][Full Text] [Related]
17. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches.
Friedman TM; Varadi G; Hopely DD; Filicko J; Wagner J; Ferber A; Martinez J; Brunner J; Grosso D; McGuire L; Korngold R; Flomenberg N
Biol Blood Marrow Transplant; 2001; 7(12):656-64. PubMed ID: 11787528
[TBL] [Abstract][Full Text] [Related]
18. Induction of tumor immunity following allogeneic stem cell transplantation.
Wu CJ; Ritz J
Adv Immunol; 2006; 90():133-73. PubMed ID: 16730263
[TBL] [Abstract][Full Text] [Related]
19. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
[TBL] [Abstract][Full Text] [Related]
20. [Modern therapy of hematologic malignancies].
Trnĕný M
Cas Lek Cesk; 2001 Nov; 140(23):711-6. PubMed ID: 11787232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
